ESR2 and colorectal carcinoma: CAL can reduce the viability of colorectal cancer (CRC) cells through targeted inhibition of PI3K/Akt signaling pathway and upregulation of Phosphatase gene (PTEN) protein and estrogen receptor ß (Erβ), thereby inducing CRC cell apoptosis.